BibTex format
@article{Van:2021:10.1056/NEJMoa2111016,
author = {Van, Mieghem NM and Unverdorben, M and Hengstenberg, C and Moellmann, H and Mehran, R and Lopez-Otero, D and Nombela-Franco, L and Moreno, R and Nordbeck, P and Thiele, H and Lang, I and Zamorano, JL and Shawl, F and Yamamoto, M and Watanabe, Y and Hayashida, K and Hambrecht, R and Meincke, F and Vranckx, P and Jin, J and Boersma, E and Rodes-Cabau, J and Ohlmann, P and Capranzano, P and Kim, H-S and Pilgrim, T and Anderson, R and Baber, U and Duggal, A and Laeis, P and Lanz, H and Chen, C and Valgimigli, M and Veltkamp, R and Saito, S and Dangas, GD},
doi = {10.1056/NEJMoa2111016},
journal = {NEW ENGLAND JOURNAL OF MEDICINE},
pages = {2150--2160},
title = {Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR},
url = {http://dx.doi.org/10.1056/NEJMoa2111016},
volume = {385},
year = {2021}
}